Passage Bio Inc.
0.58
-0.02 (-2.85%)
At close: Jan 15, 2025, 1:54 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -102.06M -136.13M -185.39M -112.23M -45.63M -12.77M
Depreciation & Amortization 3.72M 3.68M 1.54M 800.00K 134.00K n/a
Stock-Based Compensation 10.92M 18.95M 32.69M 14.58M 1.45M n/a
Other Working Capital 8.13M -3.08M 9.22M 9.85M -6.74M -8.95M
Other Non-Cash Items 3.82M 3.77M 10.07M 1.26M 952.00K 2.73M
Deferred Income Tax n/a n/a 2.78M 633.00K 9.14M n/a
Change in Working Capital 5.34M -8.49M 11.42M 14.44M -5.94M -8.52M
Operating Cash Flow -78.26M -118.21M -126.88M -80.52M -39.90M -18.57M
Capital Expenditures -146.00K -5.27M -25.64M -1.65M -1.69M -2.54M
Acquisitions n/a 3.00M 8.00M 500.00K n/a n/a
Purchase of Investments -129.43M -157.84M -202.55M -266.06M n/a n/a
Sales Maturities Of Investments 194.81M 188.31M 182.37M 95.60M n/a n/a
Other Investing Acitivies n/a -3.00M -8.00M -500.00K -500 -2.52K
Investing Cash Flow 65.24M 25.20M -45.81M -172.11M -1.69M -2.54M
Debt Repayment n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -1.35M -37.00K 284.00K 175.60M 45.97M
Financial Cash Flow 135.00K -1.35K 166.66K 228.75M 175.60M 45.97M
Net Cash Flow -12.89M -94.36M -6.04M -23.87M 134.01M 24.86M
Free Cash Flow -78.41M -123.48M -152.52M -82.17M -41.59M -21.11M